Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp167 | Cell biology: osteoblasts and bone formation | ECTS2013

Adipogenesis occurs at the expense of osteoblast differentiation in primary osteoblasts deficient in protease-activated receptor 2

Kularathna Pamuditha , Pagel Charles N , Hooper John D , Mackie Eleanor J

The G protein-coupled receptor, protease-activated receptor 2 (PAR2), is expressed by osteoblasts and required for normal skeletal growth and repair. Prostate cancer (PCa) cells commonly secrete proteolytic activators of PAR2 (including matriptase and kallikrein-related peptidase 4) and frequently form osteogenic metastases in bone. This study was undertaken to investigate the hypothesis that PAR2 activators released by PCa cells modulate osteo...

ba0002p47 | (1) | ICCBH2013

Vitamin D deficiency and structural and functional state of bone tissue in schoolchildren of Ukraine

Povoroznyuk Vladyslav , Tyazhka O , Balatska Nataliya , Budnik T , Kubey I , Haliyash N

Introduction: Vitamin D is an essential material in bone metabolism, and regulation of body minerals. Vitamin D deficiency has various causes, including limitations in sunlight exposure (type of clothing, sunscreen usage, indoor activity), seasonal geographic latitude and altitude, atmospheric pollution, diet, and ageing.The aim of the work was to determine the frequency of vitamin D deficiency among Ukrainian schoolchildren and its influence on bone min...

ba0003cc4 | (1) | ECTS2014

Two novel compound heterozygous mutations in LRP5 cause osteoporosis pseudoglioma syndrome

Alonso N , Soares D C , Kabir D , Summers G D , Ralston S H , Gregson C L

Osteoporosis pseudoglioma syndrome (OPPGS) is a rare autosomal recessive disorder characterised by congenital or juvenile-onset blindness, severe juvenile-onset osteoporosis, and skeletal fragility. OPPGS is caused by loss-of-function mutations in the LRP5 gene, a member of the LDL receptor family. It activates the canonical Wnt/β-catenin pathway, regulating osteoblastic bone formation. We investigated a 40-year-old Caucasian male presenting with congenital blind...

ba0003pp65 | Bone development/growth and fracture repair | ECTS2014

Influence of BMI on pubertal development and bone mass accrual in apparently healthy school children aged 6-17 years

Khadgawat Rajesh , Marwaha Raman , Dabas Aashima , Tandon N , Sastry A , Badra K

Aim: To evaluate progression of bone mineral density (BMD) and bone mineral content (BMC) during pubertal development and influence of body composition and vitamin D on BMD and BMC in children and adolescents.Materials and methods: This cross-sectional study was part of an ongoing health survey of Delhi school children. Total 1905 apparently healthy school children (835 boys; and 1070 girls) in the age group of 6–17 years were studied. After brief h...

ba0003pp264 | Osteoporosis: pathophysiology and epidemiology | ECTS2014

Calcium and vitamin D nutritional status effect on oral health evaluated in a group of young college women

Antonenko Olga , Pellegrini Gretel G , Somoza Julia , Britos Graciela , Bryk Gabriel , Zeni Susana N

Calcium (Ca) and vitamin D nutritional status effects on oral health were evaluated in 85 healthy women aged between 20 and 30 years (24.6±0.4). They attended the first year of the Nutrition Carrier at the Private University (ISALUD, Buenos Aires, Argentine). Usual Ca intake (CaI) was determined by a food-frequency questionnaire that included consumption of dairy products and calcium-enriched foods. Blood samples were obtained in a fasting state in winter: the end of Augu...

ba0004p114 | (1) | ICCBH2015

Influence of pubertal development and body composition on bone mass accrual in apparently healthy school children aged 6-17 years

Dabas Aashima , Khadgawat Rajesh , Marwaha R K , Mehan N , Sastry A , Badra K

Objectives: To evaluate progression of BMD and bone mineral content (BMC) during pubertal development and Influence of body composition and vitamin D on BMD and BMC in children and adolescents.Material and method: This cross sectional study was part of an ongoing health survey of Delhi school children which recruited 1905 apparently healthy school children (835 boys; 1070 girls) in the age group of 6–17 years. After brief history, anthropometry and ...

ba0005p258 | Muscle, physical activity and bone | ECTS2016

Pamidronate may prevent muscle protein breakdown in burns by indirectly affecting cytokines

Jay Jason W. , Herndon David N. , Finnerty Celeste C. , Andersen Clark R. , Klein Gordon L.

We have shown that the bisphosphonate pamidronate (P) given to children <10d post-burn prevents resorptive bone loss and muscle protein breakdown. We have also shown in vitro that Ca modulates the inflammatory response by altering mononuclear cell chemokine production. We hypothesized that P affects muscle protein breakdown by altering cytokine or chemokine concentration directly or indirectly by lowering blood ionized (i) Ca. We retrospectively analysed biomarker...

ba0006p107 | (1) | ICCBH2017

A case of a novel de novo PLS3 deletion, presenting with vertebral fractures and mild dysmorphism

Doulgeraki A. , Costantini A. , Kampe A. , Karavitakis E. , Jantti N. , Krallis P. , Athanasopoulou H. , Xaidara A. , Makitie O.

Background: Mutations in the PLS3 gene, encoding plastin 3, cause X-linked osteoporosis. Osteoporosis is characterized by low bone mineral density (BMD) and increased susceptibility to fractures. Here we describe a 7-year-old boy with osteoporosis due to a novel PLS3 deletion.Presenting problem: The patient, born to non-consanguineous parents, had a history of one low-energy long-bone fracture, three vertebral fractures (T5, T6 T8) and kyphosis. DXA scan...

ba0004p79 | (1) | ICCBH2015

Nonbacterial osteitis: Is there any mismatch in the pathophysiology of osteoblasts or osteoclasts?

Singh Delila , Pozza Susanne Bechtold-Dalla , Gesell Isabella Susanne , Schmidt Heinrich , Jansson Annette

The aim of the study is to determine whether there is an imbalance between bone formation and bone resorption in nonbacterial osteitis. The osteoclast inhibitor pamidronate has been successfully used in nonbacterial osteitis. It is assumed, that there is any mismatch in the pathophysiology of osteoblasts or osteoclasts. Until now, we have no known publications on bone metabolism in nonbacterial osteitis. We chose osteoprotegerin (OP) and alkaline phosphatase (AP) as markers of...

ba0004p109 | (1) | ICCBH2015

Effects of inorganic phosphate and FGF23 on C2C12 myoblast cells

Raimann Adalbert , Dangl Alexander , Sagmeister Susanne , Greber-Platzer Susanne , Haeusler Gabriele

Objectives: Dysregulation of systemic phosphate homeostasis is often associated with impairment of musculoskeletal tissue function. Many factors such as calcium levels and dysegulated endocrine mechanisms are thought to contribute. Inorganic phosphate and FGF23 have been shown to act via similar signaling pathways in several cell types but we are not aware of any detailed investigations into their effect on the differentiation and viability of skeletal muscle cells. W...